Jonathan Symonds, CBE, was appointed as an independent non-executive Director of HSBC Holdings plc in April 2014. He has extensive international financial and governance experience.
Mr Symonds is Chairman of HSBC Bank plc, HSBC’s European subsidiary, which offers services to clients in the UK and Continental Europe.
Mr Symonds was Chief Financial Officer of Novartis AG from 2009 to 2013. Before joining Novartis he was a Partner and Managing Director of Goldman Sachs; Chief Financial Officer of AstraZeneca plc; and a Partner at KPMG. His governance experience includes roles as non-executive Director and chair of the audit committees of Diageo plc and QinetiQ plc.
He is currently Chairman of Proteus Digital Health Inc. and a non-executive director of Genomics England Limited. He is also a non-executive director of Rubius Therapeutics, Inc..
Mr Symonds is a Fellow of the Institute of Chartered Accountants in England and Wales. He has a BA, First Class Honours in Business Finance from the University of Hertfordshire.
Independent non-executive Director, member of the Group Audit Committee, the Group Remuneration Committee and the Nomination & Corporate Governance Committee